Mawrin C.

Mawrin C. is a researcher at the German Cancer Research Center (DKFZ) in Heidelberg, Germany, specializing in neuro-oncology with a focus on meningiomas and gliomas. Their work contributes significantly to the molecular understanding and classification of central nervous system tumors.

Research interests include:

• Molecular pathology of meningiomas
• Diagnostic criteria for pediatric CNS tumors
• Genetic and epigenetic alterations in brain tumors
• Prognostic markers in glioma research
• Molecular classification systems for CNS tumors

Recent publications demonstrate a strong focus on molecular signatures that define specific tumor subtypes and their clinical implications. Mawrin C. has contributed to advancing the understanding of BAP1-altered meningiomas as a distinct tumor entity and the prognostic significance of CDKN2A/B deletions in IDH-mutant gliomas. Their work often bridges molecular discoveries with clinical applications, potentially improving diagnostic accuracy and treatment approaches.

Mawrin C. actively collaborates with researchers across institutions, as evidenced by multi-author publications in high-impact neuro-oncology journals. Their research appears in leading publications such as Neuro-Oncology, Nature Medicine, and Neuro-oncology Advances, reflecting significant contributions to the field.